A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Phase of Trial: Phase II
Latest Information Update: 28 Jan 2016
Price : $35 *
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Elcelyx Therapeutics
- 29 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jun 2014 Planned End Date changed from 1 Jul 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 02 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.